InvestorRoom | Kitov Pharmaceuticals http://kitovpharma.investorroom.com/ Kitov Announces Consensiā„¢ as Brand Name for KIT-302 http://kitovpharma.investorroom.com/news-releases?item=59 Thu, 14 Dec 2017 09:44:00 -0500 http://kitovpharma.investorroom.com/news-releases?item=59 Kitov Pharmaceuticals Announces Receipt of FDA's Favorable Response to NT219's pre-IND Meeting Package http://kitovpharma.investorroom.com/2017-11-01-Kitov-Pharmaceuticals-Announces-Receipt-of-FDAs-Favorable-Response-to-NT219s-pre-IND-Meeting-Package TyrNovo to Initiate Clinical Development on Advanced Pancreatic Cancer Patients Wed, 01 Nov 2017 09:15:00 -0400 http://kitovpharma.investorroom.com/2017-11-01-Kitov-Pharmaceuticals-Announces-Receipt-of-FDAs-Favorable-Response-to-NT219s-pre-IND-Meeting-Package Kitov Pharmaceuticals Announces Phase III/IV Clinical Trial for KIT-302 Successfully Meets Primary Endpoint, and also Demonstrates Drug Candidate Improves Renal Function http://kitovpharma.investorroom.com/Kitov-Pharmaceuticals-Announces-Phase-III-IV-Clinical-Trial-for-KIT-302-Successfully-Meets-Primary-Endpoint-and-also-Demonstrates-Drug-Candidate-Improves-Renal-Function Thu, 26 Oct 2017 14:00:00 -0400 http://kitovpharma.investorroom.com/Kitov-Pharmaceuticals-Announces-Phase-III-IV-Clinical-Trial-for-KIT-302-Successfully-Meets-Primary-Endpoint-and-also-Demonstrates-Drug-Candidate-Improves-Renal-Function Kitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for Stock http://kitovpharma.investorroom.com/2017-10-06-Kitov-Boosts-Ownership-in-TyrNovo-and-Oncology-Platform-Through-Exchange-of-Shares-for-Stock - Kitov acquires an additional 27% ownership stake in TyrNovo and NT219, its oncology therapeutic candidate, in exchange for Kitov stock at a value of $2.50 per ADS. Fri, 06 Oct 2017 08:20:00 -0400 http://kitovpharma.investorroom.com/2017-10-06-Kitov-Boosts-Ownership-in-TyrNovo-and-Oncology-Platform-Through-Exchange-of-Shares-for-Stock Kitov Announces Filing by FDA of New Drug Application for KIT-302 http://kitovpharma.investorroom.com/news-releases?item=55 Mon, 02 Oct 2017 06:36:00 -0400 http://kitovpharma.investorroom.com/news-releases?item=55